An Extended-Release Form of Clonidine as an Anti-Manic Agent: An Add-on, Open-Label Study

Summary

The investigators plan to to study an extended-release form of clonidine, which the investigators hope will be even better tolerated than the immediate-release form, as an antimanic agent. Subjects will receive an extended-release form of clonidine in addition to their usual medication regimen on the second day of this three-day study. Rating scales, a record of sleep, and a questionnaire of adverse effects will be recorded on each of the 3 days. Any medication changes made by the attending psychiatrist and prns administered will be recorded throughout the study.

Timeline

Start

2012-01

Primary completion

2013-01

Completion

2013-01

Drugs

Indications